GITNUX MARKETDATA REPORT 2024

Ai Drug Discovery Industry Statistics

The AI drug discovery industry is expected to see significant growth due to technological advancements and increasing demand for more efficient drug development processes.

Last Updated: June 22, 2024

Written & Summarized by: Jannik Lindner

How we write

In this post, we explore the latest statistics shaping the AI drug discovery industry, revealing key insights into market size, growth projections, regional trends, technological advancements, investment figures, and the transformative impact of AI on pharmaceutical research and development. From the significant market value to the promising success rates in clinical trials, these statistics shed light on the dynamic landscape of AI integration in drug discovery.

Statistic 1

"The global AI in drug discovery market size was valued at $473.4 million in 2019."

Statistic 2

"The global AI in drug discovery market is expected to grow at a compound annual growth rate (CAGR) of 40.5% from 2020 to 2027."

Statistic 3

"North America holds the largest market share (42.9%) in 2019 in the AI drug discovery market."

Statistic 4

"Approximately 52% of AI drug discovery startups are US-based."

Statistic 5

"The machine learning segment is anticipated to witness the fastest growth rate of 41.0% over the forecast period in AI drug discovery."

Statistic 6

"AI drug discovery investments totaled $13.8 billion in 2020."

Statistic 7

"Oncology accounted for 32% of the AI drug discovery industry in 2019."

Statistic 8

"AI technology can decrease the drug discovery timeline by four years and save $26 billion in drug discovery costs."

Statistic 9

"AI in drug discovery has led to a 35% success rate in phase II clinical trials, as compared to the industry standard of 10%."

Statistic 10

"About 40% of AI drug discovery startups focus on AI-driven drug repositioning."

Statistic 11

"By 2024, AI systems could find a use in nearly 90% of USA pharmaceutical companies."

Statistic 12

"The neural networks segment had substantial growth accounting for revenue of $78.2 million in 2019 in the AI drug discovery market."

Statistic 13

"In 2020, there were more than 480 partnerships between AI companies and traditional pharmaceutical firms."

Statistic 14

"By 2027, AI in drug discovery is predicted to have a market worth of $3,932 million."

Statistic 15

"80% of pharmaceutical and healthcare executives have said they have started to invest in AI."

Statistic 16

"By 2025, total public and private sector investment in healthcare AI is predicted to reach $6.6 billion."

The statistics presented indicate a significant and rapid growth in the AI drug discovery industry, with North America leading the market. The projected market size and investment numbers demonstrate strong confidence and interest in AI technologies for drug discovery. The potential benefits of AI in reducing drug discovery timelines, improving success rates in clinical trials, and fostering partnerships between AI companies and pharmaceutical firms all point towards a promising future for the industry. The increasing adoption of AI systems by pharmaceutical companies further solidifies the role of AI in revolutionizing drug discovery processes. With substantial growth predicted and a high level of investment expected in the coming years, it is clear that AI will continue to play a crucial role in shaping the future of drug discovery.

Jannik Lindner

Jannik is the Co-Founder of Gitnux and has been working in the digital space since 2016. He is specialized in content and tech.

Can You Trust Our Report?

The statistics are checked by us and then entered into the database. Our market data reports have been linked to by some of the largest publishers and companies on the Internet.

Learn more about our process here.